Passage Bio, Inc.

PASG · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$37,573$21,709$34,601$128,965
Short-Term Investments$39,183$92,585$155,009$186,808
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,059$3,665$7,434$9,293
Total Curr. Assets$78,815$117,959$197,044$325,066
Property Plant & Equip (Net)$23,134$32,153$42,238$23,806
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$463$433$4,267$6,204
Total NC Assets$23,597$32,586$46,505$30,010
Other Assets$0$0$0$0
Total Assets$102,412$150,545$243,549$355,076
Liabilities
Payables$742$1,298$4,065$9,448
Short-Term Debt$3,688$3,373$3,275$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$14,933$11,670$11,011$20,050
Total Curr. Liab.$19,363$16,341$18,351$29,498
LT Debt$21,788$22,921$23,832$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$6,921
Total NC Liab.$21,788$22,921$23,832$6,921
Other Liabilities$0$0$0$0
Cap. Leases$21,788$26,294$27,107$0
Total Liabilities$41,151$39,262$42,183$36,419
Equity
Pref Stock$0$0$0$0
Common Stock$6$5$5$5
Retained Earnings-$659,235-$594,468-$492,406-$356,281
AOCI$8-$43-$966-$413
Other Equity$720,482$705,789$694,733$675,346
Total Equity$61,261$111,283$201,366$318,657
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$102,412$150,545$243,549$355,076
Net Debt-$12,097$4,585-$7,494-$128,965